Assessment of In-Vitro Synergy of Fosfomycin with Meropenem, Amikacin and Tigecycline in Whole Genome Sequenced Extended and Pan Drug Resistant Klebsiella Pneumoniae: Exploring A Colistin Sparing Protocol

Fosfomycin has emerged as a very useful antimicrobial in management of extremely drug resistant (XDR) and pan drug resistant (PDR) Klebsiella pneumoniae. In this study, we assessed in-vitro synergy of colistin sparing combinations of fosfomycin (FOS) with meropenem (MEM), tigecycline (TGC) and amika...

Descripción completa

Detalles Bibliográficos
Autores principales: AL-Quraini, Manawr, Rizvi, Meher, AL-Jabri, Zaaima, Sami, Hiba, AL-Muzahmi, Muna, AL-Muharrmi, Zakariya, Taneja, Neelam, AL-Busaidi, Ibrahim, Soman, Rajeev
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868363/
https://www.ncbi.nlm.nih.gov/pubmed/35203756
http://dx.doi.org/10.3390/antibiotics11020153

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8868363/
https://www.ncbi.nlm.nih.gov/pubmed/35203756
http://dx.doi.org/10.3390/antibiotics11020153

Ejemplares similares